Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Trends > Health claims

Chr Hansen shares jump 9% on strong H1 profits

By Shane Starling , 19-Apr-2012
Last updated on 20-Apr-2012 at 09:38 GMT2012-04-20T09:38:22Z

Chr Hansen shares jump 9% on strong H1 profits

First half EBIT profits for 2011-12 surged 19% to €83m at Chr Hansen as it shrugged off the effects of severe fluctuations in the price of red colorant carmine, and ongoing probiotic health claim uncertainty in Europe – its biggest yet most stagnant market.

The announcement sent its share price up almost 8.91% to 157.6 Danish kroners at the time of going to press.

Company-wide organic growth was 11% for the half ended February 29 which meant revenues reached €332.5m for the half compared to €304.2m in the first half of 2010-2011.

CEO Lars Frederiksen told this publication the carmine situation saw prices peak at about €90 a kilogram a year ago compared to around €27/kg today.

“We have been forced to pass through pricing to customers,” he said, but noted that most of that extreme pricing had occurred in 2011.

With more stable carmine prices, strong growth in emerging markets, and some reality-checking in the European regulatory scene in regard to probiotic claims especially, the company had upped its revenue growth forecasts from 7-10% to 8-10%.

It has also engaged in a share buy-back scheme to the tune of €80m over the next six months, with further investment possible later in the year. “We have a lot of options,” said Frederiksen in a webcast this morning.

He added of the buy-back that its, “pure purpose is to adjust the capital structure.”

Divisions, regions, regulations

The Danish natural colours, enzymes and cultures specialist’s Health and Nutrition division grew fastest at 16% with good gains in Asia and South America, especially in infant formulas, fermented milks and probiotics along with animal feed. Cultures and Enzymes grew 9%; Natural Colours 8%.

In North America enzymes had performed well in the cheese and fermented drinks sector while probiotics had declined.

But Health and Nutrition (€47.4m) represented only 14% of overall revenues compared to 26% for Colours (€86.8m) and 60% for Cultures and Enzymes (€198.3m).

South America registered the strongest organic growth at 26% compared to 15% for North America, 8% for Asia Pacific and the Middle East and 4% for Europe.

In the morning’s webcast chief financial officer, Klaus Pederson, said the company was investing in at least two clinical trials for its probiotic strains in the gastro-immunity area, with results expected by the end of the year.

R&D spend stayed stable at €24 or 7% of revenue.

Frederiksen said the ambiguity and negativity around probiotics created by the EU nutrition and health claim regulation (NHCR) that has not yet approved a single probiotic health claim, was tapering as the market adjusted to the new realities.

“The probiotics market is flat now but that is after three quarters of negative growth and perhaps that is proof that the whole issue has been over-exaggerated. Most of our customers have removed their claims already so there is no significant impact of this.”

Q2 revenues came in at €165m – a 9% organic growth.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars